Medical/Pharmaceuticals
Backed by $2 Million, Droplet IV is Set to Launch its Revolutionary Automatic IV-Line Flushing Device in EU & US in 2026
COPENHAGEN, Denmark, June 18, 2025 /PRNewswire/ -- Droplet IV today announced the successful completion of a $2 million funding round to enable launch of its first automatic IV-line flushing device in the EU and US markets. The device addresses a critical need among nurses, who currently spend si...
2025-06-18 23:35
2451
Medison Expands Global Leadership Team with Chief Business Officer and Chief Legal & Compliance Officer
Strategic appointments reflect Medison's continued investment in global scale
and operational excellence
PETACH TIKVA, Israel, June 18, 2025 /PRNewswire/ -- Medison
2025-06-18 22:41
2044
Medison Expands Global Leadership Team with Chief Business Officer and Chief Legal & Compliance Officer
Strategic appointments reflect Medison's continued investment in global scale
and operational excellence
PETACH TIKVA, Israel, June 18, 2025 /PRNewswire/ -- Medison
2025-06-18 22:36
1859
Paradigm Therapeutics, Inc. Announces an Additional Investment by Eshelman Ventures, LLC to Expedite Global Development and Global Registration of SD-101, A Topical Therapy for Treatment Across the Entire Skin Surface of All Subtypes of Epidermolysis Bullosa (EB)
First Topical Therapy Developed to Treat the Wounds and Lesions on the Entire Skin Surface Across All EB Subtypes Funding to be Used to Accelerate Activities Associated with Increasing Manufacturing Development of SD-101 and Commercial Launch of the SD-101 Program Globally. MT PLEASANT, S.C.,...
2025-06-18 22:00
2264
Embla Medical Recognized for Leadership in Accessibility and International Reach
Company honored by Forbes Magazine for Championing Accessibility and by Iceland's President for Excellence in Global Exports REYKJAVÍK, Iceland, June 18, 2025 /PRNewswire/ -- Embla Medical (NASDAQ Copenhagen: EMBLA), a leading global provider of innovative mobility solutions, is being internati...
2025-06-18 20:13
1822
Largest Australian Health Insurer to Fund Innovative PTSD Treatment Program
PERTH, Australia, June 18, 2025 /PRNewswire/ -- Emyria Limited (ASX: EMD) ("Emyria", or the "Company") a leader in developing and delivering innovative mental health treatments, today announced a landmark partnership with Medibank, Australia's largest private health insurer. Under the multi-yea...
2025-06-18 20:00
2517
ASTRI and Pok Oi Sign MoU to Explore Innovative Technologies for Lam Tei Project
Aims to Create Hong Kong's Largest Smart Care Home HONG KONG, June 18, 2025 /PRNewswire/ -- The Hong Kong Applied Science and Technology Research Institute (ASTRI) and the Board of Directors of Pok Oi Hospital (Pok Oi) signed a Memorandum of Understanding (MoU) today to collaborate on exploring...
2025-06-18 18:28
2592
WuXi AppTec Earns SBTi Validation for Near-Term Emissions Reduction Targets
SHANGHAI, June 17, 2025 /PRNewswire/ -- WuXi AppTec, a global company that provides a broad portfolio of R&D and manufacturing services to enable companies in the pharmaceutical and life science industries, announced that the Science Based Targets initiative (SBTi) has approved WuXi AppTec's near...
2025-06-18 08:00
2332
Peer-Reviewed Study in Nature Scientific Reports Demonstrates Non-Invasive Fat Reduction Using Alma's Energy-Based Technology
CAESAREA, Israel, June 18, 2025 /PRNewswire/ -- A newly published,
peer-reviewed study in Nature Scientific Reports
2025-06-18 07:00
2160
AI-Powered CDSS Enhances Patient Safety with Real-World Data
SAN FRANCISCO, June 17, 2025 /PRNewswire/ -- The growing demand for
personalized medicine has accelerated the adoption of Real-World Data (RWD) in
healthcare.The Tungs' Taichung MetroHarbor Hospital
2025-06-18 00:05
2130
RemeGen's Telitacicept (RC18) Received Orphan Drug Designation from EMA for Myasthenia Gravis
YANTAI, China, June 17, 2025 /PRNewswire/ -- On June 16, 2025, RemeGen Co., Ltd. ("RemeGen", stock symbols: 688331.SH/09995.HK) announced that telitacicept (RC18; brand name: 泰爱®) has received Orphan Drug Designation (ODD) from European Medicines Agency (EMA) for the treatment of Myasthenia Gravi...
2025-06-17 23:16
2645
Skyhawk Therapeutics Announces First Patient Dosed in Phase 2/3 FALCON-HD Trial of SKY-0515 for Huntington's Disease
SKY-0515 is an oral small molecule designed to reduce the production of both huntingtin (HTT) and PMS1 proteins—two key drivers of HD pathology Initiation of the FALCON-HD trial follows promising Phase 1 results demonstrating up to 72% reduction in HTT mRNA in healthy volunteers The SKY-0515 P...
2025-06-17 22:00
1756
Clarity enters a Commercial Manufacturing Agreement for Cu-64 SAR-bisPSMA with SpectronRx
Highlights * Clarity has entered into a Commercial Manufacturing Agreement with SpectronRx for64Cu-SAR-bisPSMA. * SpectronRx's facility in Indiana will provide on-demand commercial-scale manufacturing of both copper-64 and64Cu-SAR-bisPSMA under one roof and enables distribution to all 50 sta...
2025-06-17 21:04
2498
Brain Navi achieves U.S. FDA approval for neurosurgical robot NaoTrac
ZHUBEI CITY, June 17, 2025 /PRNewswire/ -- Brain Navi Biotechnology, a medical robotics company founded in 2015 in Taiwan by surgeon and serial entrepreneur Jerry Chen, has reached another major milestone. Following previous approvals from the Taiwan Food and Drug Administration (TFDA) and the CE...
2025-06-17 21:00
2054
SmartLabs and IWG Announce 10-Year Partnership to Deliver Fully Managed Lab Infrastructure Worldwide
First-of-its-kind collaboration will integrate SmartLabs' turnkey laboratory solutions across IWG's global portfolio of flexible workspace brands BOSTON and ZUG, Switzerland, June 17, 2025 /PRNewswire/ -- SmartLabs, the leading provider of flexible laboratory infrastructure and resourcing solut...
2025-06-17 19:00
2192
HanchorBio Presents Promising Data on HCB101 Checkpoint Inhibitor Immunotherapy at ASCO
Interim data on the cancer treatment shows robust potential for balancing
efficacy and safety
TAIPEI and SHANGHAI and SAN FRANCISCO, June 17, 2025 /PRNewswire/ --
Following a successful launch of Phase 2 clinical trials in March, HanchorBio
2025-06-17 18:00
1570
VSA Signs Letter of Intent to Acquire HopeAI, Accelerating Expansion into AI in Life Science
BEIJING, June 17, 2025 /PRNewswire/ -- TCTM Kids IT Education Inc. (Nasdaq: VSA) (the "Company" or "VSA") today announced that it has entered into a non-binding letter of intent ("LOI") to acquire HopeAI Inc. ("HopeAI"), a leading artificial intelligence company specializing in AI-powered clinica...
2025-06-17 16:30
4304
Corvia Medical closes $55 million funding round to complete confirmatory trial and pursue FDA approval of Corvia Atrial Shunt
Existing investors provide funding to finish international RESPONDER-HF trial TEWKSBURY, Mass., June 17, 2025 /PRNewswire/ -- Corvia Medical, Inc, a company dedicated to transforming the treatment of heart failure, today announced the successful closure of a $55 million funding round from the ...
2025-06-17 16:00
1565
Clover Initiates Phase I Clinical Trial for RSV + hMPV ± PIV3 Respiratory Combination Vaccine Candidates
-- Potential First-in-Class Respiratory Combination Vaccine Candidates SCB-1022
(RSV + hMPV) and SCB-1033 (RSV + hMPV + PIV3) Enter the Clinical Trial Stage --
SHANGHAI, June 17, 2025 /PRNewswire/ -- Clover Biopharmaceuticals, Ltd.
2025-06-17 12:48
2094
International Pharmaceuticals, Inc. Partners with Anchanto to Power E-commerce Operations in the Philippines
CEBU CITY, Philippines, June 17, 2025 /PRNewswire/ -- Anchanto, the leading global B2B SaaS technology company in e-commerce and supply chain, announced its latest partnership with International Pharmaceuticals, Inc. (IPI), one of Philippines' leading manufacturer and distributor of pharmaceutica...
2025-06-17 11:07
2064
Week's Top Stories
Most Reposted
Edufrienz 99: One of Asia's First Digital Platform Advancing Character Education for Future-Ready, Compassionate Children
[Picked up by 316 media titles]
2026-01-23 11:03
UOB prices AUD2 billion in five-year senior unsecured notes
[Picked up by 305 media titles]
2026-01-23 09:00Agoda Launches Open-Source API Agent to Simplify MCP Server Integrations
[Picked up by 300 media titles]
2026-01-27 13:00
AVPN's AI Opportunity Fund Expands Regional Efforts to Build AI Skilling Infrastructure for a Future-Ready Workforce Across Asia-Pacific
[Picked up by 299 media titles]
2026-01-21 12:39Government of Telangana and Blaize Sign MoU at Davos to Launch Telangana AI Innovation Hub and Advance Applied AI Initiatives
[Picked up by 297 media titles]
2026-01-22 15:16
